Stiborová M, Hájek M, Frei E, Schmeiser H H
Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.
Gen Physiol Biophys. 2001 Dec;20(4):375-92.
Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, has been found to be implicated in an unique type of renal fibrosis, designated Chinese herbs nephropathy (CHN), and associated with the development of urothelial cancer in CHN patients. Understanding, which enzymes are involved in AA activation and/or detoxication is important in the assessment of individual susceptibility of humans to this natural carcinogen. Using the nuclease P1 version of the 32P-postlabeling assay we examined the ability of microsomal NADPH: CYP reductase to activate AA to metabolites forming DNA adducts. Renal and hepatic microsomes, containing NADPH:CYP reductase, generated AA-DNA adduct patterns reproducing those found in renal tissues in patients suffering from a renal fibrosis CHN and urothelial cancer. 7-(Deoxyadenosin-N6-yl)aristolactam I, 7-(deoxyguanosin-N2-yl)aristolactam I and 7-(deoxyadenosin-N6-yl)aristolactam II were identified as AA-DNA adducts formed by AAI. Two AA-DNA adducts, 7-(deoxyguanosin-N2-yl) aristolactam II and 7- (deoxyadenosin-N6-yl) aristolactam II, were generated from AAII. According to the structures of the DNA adducts identified, nitroreduction is the crucial pathway in the metabolic activation of AA. The identity of NADPH: CYP reductase as activating enzyme in microsomes has been proved with different cofactors and an enzyme inhibitor. Alpha-lipoic acid, a selective inhibitor of NADPH: CYP reductase, significantly decreased the amount of the adducts formed by microsomes. Likewise, only a cofactor of the enzyme, NADPH, supported the DNA adduct formation of AAI and AAII, while NADH was ineffective. These results demonstrate an involvement of NADPH: CYP reductase in the activation pathway of AAI and AAII in the microsomal system. Moreover, using the purified enzyme, the participation of this enzyme in the formation of AA-DNA adducts was confirmed. The results presented here are the first report demonstrating a reductive activation of natural nitroaromatic compounds, AA, by NADPH: CYP reductase.
马兜铃酸(AA)是一种天然存在的肾毒素和致癌物,已被发现与一种独特类型的肾纤维化有关,这种肾纤维化被称为中草药肾病(CHN),并且与CHN患者的尿路上皮癌的发生有关。了解哪些酶参与AA的活化和/或解毒对于评估人类对这种天然致癌物的个体易感性很重要。我们使用32P后标记分析的核酸酶P1版本,研究了微粒体NADPH:CYP还原酶将AA活化为形成DNA加合物的代谢物的能力。含有NADPH:CYP还原酶的肾和肝微粒体产生的AA-DNA加合物模式与患有肾纤维化CHN和尿路上皮癌的患者肾组织中发现的模式一致。7-(脱氧腺苷-N6-基)马兜铃内酰胺I、7-(脱氧鸟苷-N2-基)马兜铃内酰胺I和7-(脱氧腺苷-N6-基)马兜铃内酰胺II被鉴定为AAI形成的AA-DNA加合物。两种AA-DNA加合物,7-(脱氧鸟苷-N2-基)马兜铃内酰胺II和7-(脱氧腺苷-N6-基)马兜铃内酰胺II,由AAII产生。根据鉴定出的DNA加合物的结构,硝基还原是AA代谢活化的关键途径。通过不同的辅因子和一种酶抑制剂,已证明NADPH:CYP还原酶作为微粒体中的活化酶的身份。α-硫辛酸是NADPH:CYP还原酶的选择性抑制剂,它显著降低了微粒体形成的加合物的量。同样,只有该酶的辅因子NADPH支持AAI和AAII的DNA加合物形成,而NADH则无效。这些结果表明NADPH:CYP还原酶参与了微粒体系统中AAI和AAII的活化途径。此外,使用纯化的酶,证实了该酶参与AA-DNA加合物的形成。此处呈现的结果是首次报道证明NADPH:CYP还原酶对天然硝基芳香化合物AA的还原活化作用。